1 December 2019 - 30 November 2020
Principal institution: Harvard Medical School (HMS)
Subject/journal group: All
The table to the right includes counts of all research outputs for Harvard Joslin Diabetes Center published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Outputs by subject (Share)
Top articles by Altmetric score in current window
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice
Science Translational Medicine
Affiliated joint institutions and consortia
- Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC), United States of America (USA)
- Harvard Stem Cell Institute (HSCI), United States of America (USA)
- ImmGen Consortium, United States of America (USA)
- K.G. Jebsen Center for Diabetes Research, Norway
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.